The development, optimization and validation of an ELISA bioanalytical method for the determination of Cetuximab in human serum
Abstract
Cetuximab is a chimeric IgG1 monoclonal
* Corresponding authors
a
Millipore, Inc., 15 Research Park Dr. St. Charles, MO, USA
E-mail:
jamil_hantash@millipore.com, mary_smidt@millipore.com, ron_bowsher@millipore.com
Fax: +636-442-6058
Tel: +636-441-8400
Cetuximab is a chimeric IgG1 monoclonal
J. Hantash, M. Smidt and R. R. Bowsher, Anal. Methods, 2009, 1, 144 DOI: 10.1039/B9AY00027E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content